[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
Bleeding avoidance strategies in percutaneous coronary intervention
For many years, bleeding has been perceived as an unavoidable consequence of strategies
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …
Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS
Background: Dual-antiplatelet therapy with aspirin and clopidogrel after percutaneous
coronary intervention reduces the risk for coronary thrombotic events (CTEs) at the expense …
coronary intervention reduces the risk for coronary thrombotic events (CTEs) at the expense …
Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO])
M Gilard, D Blanchard, G Helft, D Carrier… - The American journal of …, 2009 - Elsevier
We evaluated the safety and efficacy of dual antiplatelet therapy, in association with oral
anticoagulant (OAC) therapy, in patients undergoing percutaneous coronary intervention …
anticoagulant (OAC) therapy, in patients undergoing percutaneous coronary intervention …
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
JJ Popma, P Berger, EM Ohman, RA Harrington… - Chest, 2004 - Elsevier
This chapter about antithrombotic therapy during percutaneous coronary intervention (PCI)
is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy …
is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy …
Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention
Background: Platelet inhibition after percutaneous coronary intervention (PCI) reduces the
risk of myocardial infarction (MI) but increases the risk of bleeding. MIs and bleeds during …
risk of myocardial infarction (MI) but increases the risk of bleeding. MIs and bleeds during …
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Background Whether guided selection of antiplatelet therapy in patients undergoing
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …
Medical management after coronary stent implantation: a review
ES Brilakis, VG Patel, S Banerjee - Jama, 2013 - jamanetwork.com
Importance Percutaneous coronary intervention (PCI) with stents is currently the most
commonly performed coronary revascularization procedure; hence, optimizing post-PCI …
commonly performed coronary revascularization procedure; hence, optimizing post-PCI …
Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized …
Background: The optimal duration of antiplatelet therapy (APT) in patients at high bleeding
risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear …
risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear …
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
Since its introduction in 1977, percutaneous coronary intervention has become one of the
most commonly performed therapeutic procedures worldwide. Such widespread diffusion …
most commonly performed therapeutic procedures worldwide. Such widespread diffusion …